CBL Insider Trading

Insider Ownership Percentage: 69.13%
Insider Buying (Last 12 Months): A$14,200.00
Insider Selling (Last 12 Months): A$0.00

Control Bionics Insider Trading History Chart

This chart shows the insider buying and selling history at Control Bionics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Control Bionics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 03/23/2021 11:06 AM ET

This chart shows the closing price history over time for CBL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Control Bionics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/24/2024Peter FordInsiderBuy180,000A$0.06A$9,900.00
6/3/2024Peter FordInsiderBuy100,000A$0.04A$4,300.00
12/12/2023Damian LismoreInsiderIssued499,443A$0.04A$19,977.72
10/11/2023Jeremy SteeleInsiderIssued315,789A$0.07A$22,105.23
8/1/2023Jeremy SteeleInsiderIssued151,515A$0.10A$14,393.93
2/27/2023Jeremy SteeleInsiderIssued2,000,000A$0.17A$340,000.00
12/20/2022Peter FordInsiderTransfer5,202,740A$0.15A$780,411.00
7/25/2022Peter FordInsiderExercise3,567,860A$0.21A$749,250.60
4/13/2022Lindsay PhillipsInsiderBuy74,425A$0.40A$30,067.70
12/23/2021Robert WongInsiderExercise3,365,678A$0.21A$706,792.38
11/9/2021Lindsay PhillipsInsiderBuy70,256A$0.47A$32,739.30
10/29/2021Lindsay PhillipsInsiderBuy79,744A$0.49A$39,154.30
9/27/2021Lindsay PhillipsInsiderBuy18,000A$0.66A$11,862.00
9/20/2021Lindsay PhillipsInsiderBuy71,991A$0.65A$46,650.17
See Full Table

SEC Filings (Institutional Ownership Changes) for Control Bionics (ASX:CBL)

12.94% of Control Bionics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.
Read More on Control Bionics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Control Bionics?

Control Bionics' top insider shareholders include:
  1. Damian Lismore (Insider)
  2. Jeremy Steele (Insider)
  3. Peter Ford (Insider)
Learn More about top insider investors at Control Bionics.